Akili announces leadership transition

Boston--(business wire)--akili, inc. (nasdaq: akli), a leading digital medicine company, today announced that eddie martucci transitioned to the role of board chair, and matt franklin has been appointed to serve as president and ceo of the company and as a member of its board of directors, effective october 5, 2023. martucci replaces former board chair, chamath palihapitiya, who has resigned from the board, effective october 4, 2023. the leadership transition follows the company's announcement.
AKLI Ratings Summary
AKLI Quant Ranking